Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

March 16, 2011

Primary Completion Date

December 7, 2023

Study Completion Date

December 7, 2023

Conditions
Prostate Cancer
Interventions
DRUG

Abiraterone Acetate

1000 mg by mouth each day of a 28 day cycle.

DRUG

Prednisone

5 mg by mouth twice daily of a 28 day cycle.

DRUG

Sunitinib

37.5 mg by mouth daily for two weeks followed by a week of rest in a 28 day cycle.

DRUG

Dasatinib

100 mg by mouth each day of a 28 day cycle.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Janssen Scientific Affairs, LLC

INDUSTRY

collaborator

Pfizer

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER